SARS-CoV2 Vaccination immunogenicity in Immunosuppressed inflammatory bowel disease Patients.
Joined June 2021
- Tweets57
- Following50
- Followers143
- Likes50
☀️☀️@VIPStudy1 is fully open at all sites ➡️ vipstudy.uk
📢IBD and no IBD folk ➡️ covid vaccination study.
✅Have you had 2 doses of 💉 < 92 days ago?
✅IBD patients 👉 on only:
Vedo
IFX
Aza/MP
Tofu
Uste
+ IFX + Aza/MP
Check out 👉redcap.exe.nhs.uk/surveys/?s…
Congratulations #Jamesalexander 🙌
Congratulations to Dr James Alexander on being awarded the @BSGTrainees Young Gastroenterologist of the Year Award 👏
VIP Study retweeted
What's the relationship between mood and physical health, when it comes to Crohn's and Colitis?
The @mindbody_ibd is investigating that very question, and they're offering £15 worth of vouchers to those taking part.
Find out more 👇
crohnsandcolitis.org.uk/get-…
👀More data from @VIPStudy1
Main message for #IBDpatients -
✔️ get NEW boosters = protection against Omicron variants.
New boosters especially ☑️☑️ for those on anti -TNF and tofacitinib drugs.
#COVID19Ab
#IBD
@AGA_Gastro
@NickPowellLab
gastrojournal.org/article/S0…
👀More data from @VIPStudy1
Main message for #IBDpatients -
✔️ get NEW boosters = protection against Omicron variants.
New boosters especially ☑️☑️ for those on anti -TNF and tofacitinib drugs.
#COVID19Ab
#IBD
@AGA_Gastro
@NickPowellLab
VIP Study retweeted
Beautifully presented James Alexander. There is a lot of research fatigue around covid. REMEMBER covid vaccines work in IBD. Even when our drugs impair that response, further boosters “rescue’ the deficit. GET YOUR BOOSTER this Autumn.
Great to see Dr James Alexander @ImperialMDR @IHepatology presenting the latest results from the @VIPStudy1 at @my_ueg #UEGWeek, exploring immune responses after 3rd dose of #COVID19 vaccination in #IBD patients - paper on this now out in @LancetGastroHep: thelancet.com/journals/langa…
VIP Study retweeted
Great to see Dr James Alexander @ImperialMDR @IHepatology presenting the latest results from the @VIPStudy1 at @my_ueg #UEGWeek, exploring immune responses after 3rd dose of #COVID19 vaccination in #IBD patients - paper on this now out in @LancetGastroHep: thelancet.com/journals/langa…
VIP Study retweeted
The last of the late breakers is presented by James Alexander @ImperialMDR, with data from @VIPStudy1 looking at COVID-19 vaccine-induced antibody & T-cell responses in immunosuppressed patients with inflammatory bowel disease after the 3rd vaccine dose #UEGWeek #gitwitter #IBD
VIP Study retweeted
The latest @LancetGastroHep podcast is now online—I had the pleasure of speaking to James Alexander of @ImperialMDR about the latest @VIPStudy1 data on #COVID19 vaccine responses in patients with #IBD
Listen: buzzsprout.com/1728646/11442…
Paper: thelancet.com/journals/langa…
Our latest issue is now available at thelancet.com/gastrohep - incl content on #water & #sanitation, #rectalcancer surgery, #colorectalcancer #screening, #ulcerativecolitis, #COVID19, #hepatocellularcarcinoma in sub-Saharan #Africa & more!
#gitwitter #livertwitter #medtwitter
Our very own #jamesalexander talking to @lancetGastroHep
👇👇👇👇
In conversation with... James Alexander thelancet.com/doi/story/10.1…
VIP Study retweeted
Latest findings from the @VIPStudy1: a third dose of SARS-CoV-2 vaccine resulted in antibody levels significantly higher than after the second dose in patients with #IBD, irrespective of type of immunosuppressive therapy (1/6)
thelancet.com/journals/langa… #gitwitter #covid19
VIP Study retweeted
…and James is hard at work again! Now presenting his work in @NickPowellLab @ImperialMDR the influence of the gut #microbiome and #metabolome upon immune responses to #COVID19 vaccines in #IBD patients… preprint online here: doi.org/10.21203/rs.3.rs-167… @NPCUK1
Poster Prize! Well done James, #DDW2022
James Alexander @ImperialMDR presenting the work from him and @NickPowellLab from the @VIPStudy1, assessing impact of immune responses to #COVID19 vaccines in immunosuppressed #IBD patients - out now in full in @LancetGastroHep: thelancet.com/journals/langa…
VIP Study retweeted
James Alexander @ImperialMDR presenting the work from him and @NickPowellLab from the @VIPStudy1, assessing impact of immune responses to #COVID19 vaccines in immunosuppressed #IBD patients - out now in full in @LancetGastroHep: thelancet.com/journals/langa…
VIP Study retweeted
Withdrawal of @BritSocGastro IBD risk grid for COVID severity @Gut_BMJ
• reassuring for patients, with
• vaccines, boosters and antivirals
"We predict that the disruption from the pandemic for individuals with IBD will largely be no different to the general population."
VIP Study retweeted
If you fancy hearing more about the gut and research we have been doing at Imperial - come along and join us. All welcome…
Join @GutsCharityUK & @ImperialBRC in 2 weeks time, 26 April 22 5.30pm - 7.30pm, for a community event at Ealing Town Hall.
Learn about the hidden world inside your gut, meet researchers deciphering it & tell us what's important to you about gut health!
▶️science-of-digestion.eventbr…
VIP Study retweeted
#ECCO22
⏺ impaired anti-S RBD antibodies with TNFi and Tofa
J Alexander with @VIPStudy1 study data
Full paper now published 👇
thelancet.com/journals/langa…
VIP Study retweeted
James Alexander presents data from the @VIPStudy1 on
#COVID19 vaccine-induced antibody responses in patients with #IBD #ECCO2022 #GITwitter
VIP Study retweeted
Tomorrow marks the start of #ECCO2022 and a busy few days for @NickPowellLab We have two talks in the main scientific programme: James Alexander with the latest @VIPStudy1 (Fri @ 15.44 CET, 14.44 GMT) and myself talking all things fistula! (Fri @ 14.30 CET, 13.30 GMT)